These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36936753)

  • 21. Expression of Janus Kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case-control study.
    Nada HR; El Sharkawy DA; Elmasry MF; Rashed LA; Mamdouh S
    Arch Dermatol Res; 2018 Jan; 310(1):39-46. PubMed ID: 29127481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.
    Liu LY; Strassner JP; Refat MA; Harris JE; King BA
    J Am Acad Dermatol; 2017 Oct; 77(4):675-682.e1. PubMed ID: 28823882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
    Doghaim NN; El-Tatawy RA; Ismail MA; Ali DAM; El Attar YA
    J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of using fractional CO
    Ghasemloo S; Gauthier Y; Ghalamkarpour F
    J Dermatolog Treat; 2019 Nov; 30(7):697-700. PubMed ID: 30592235
    [No Abstract]   [Full Text] [Related]  

  • 25. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo.
    Zhang DM; Hong WS; Fu LF; Wei XD; Xu AE
    Dermatol Surg; 2014 Apr; 40(4):420-6. PubMed ID: 24446755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
    Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tacrolimus (FK506) ointment combined with Nb-UVB could activate both hair follicle (HF) and dermal melanocyte precursors in vitiligo: the first histopathological and clinical study.
    Gauthier Y; Almasi-Nasrabadi M; Cario-André M; Pain C; Rakhshan A; Ghalamkarpour F
    Arch Dermatol Res; 2021 Jul; 313(5):383-388. PubMed ID: 32303824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JAK inhibitors in vitiligo: what they hit and what they miss - an immunopathogenesis based exposition of existing evidence.
    Sardana K; Muddebihal A; Khurana A
    Expert Rev Clin Pharmacol; 2023; 16(12):1221-1227. PubMed ID: 37982238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitiligo, NB-UVB and tacrolimus: our experience in Naples.
    Baldo A; Lodi G; Di Caterino P; Monfrecola G
    G Ital Dermatol Venereol; 2014 Feb; 149(1):123-30. PubMed ID: 24566573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of needling/microneedling as an adjunct to phototherapy in the treatment of stable acral vitiligo: a comparative clinical and immunohistochemical study.
    Esmat S; Assaf MI; Mohye Eldeen R; Gawdat HI; Saadi DG
    J Dermatolog Treat; 2022 Aug; 33(5):2621-2628. PubMed ID: 35373693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro.
    Dong J; Huang X; Ma LP; Qi F; Wang SN; Zhang ZQ; Wei SN; Gao L; Liu F
    Dose Response; 2022; 20(2):15593258221105370. PubMed ID: 35663493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of melanocortin 1 receptor before and after narrowband UVB phototherapy treatment in patients with stable vitiligo: A prospective study.
    Ocampo-Garza J; Salinas-Santander M; Welsh O; Herz-Ruelas M; Ocampo-Candiani J
    Exp Ther Med; 2020 Mar; 19(3):1649-1654. PubMed ID: 32104216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G; Pacifico A; Iacovelli P; Paro Vidolin A; Picardo M
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility, double-blind, randomised, placebo-controlled, multi-centre trial of hand-held NB-UVB phototherapy for the treatment of vitiligo at home (HI-Light trial: Home Intervention of Light therapy).
    Eleftheriadou V; Thomas K; Ravenscroft J; Whitton M; Batchelor J; Williams H
    Trials; 2014 Feb; 15():51. PubMed ID: 24507484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW; Grimes PE; Agbai O; Hamzavi I; Henderson M; Haddican M; Linkner RV; Lebwohl M
    JAMA Dermatol; 2015 Jan; 151(1):42-50. PubMed ID: 25230094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic and targeted therapeutics in vitiligo.
    Karagaiah P; Schwartz RA; Lotti T; Wollina U; Grabbe S; Goldust M
    J Cosmet Dermatol; 2023 Jan; 22(1):64-73. PubMed ID: 35029034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phototherapy for vitiligo, what's new?
    Paro Vidolin A; Aurizi C; Leone G
    G Ital Dermatol Venereol; 2017 Oct; 152(5):474-488. PubMed ID: 28906087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narrow-band UVB effects on cutaneous vitamin D receptor expression and serum 25-hydroxyvitamin D in generalized vitiligo.
    El-Hanbuli HM; Dawoud NM; Mahmoud RH
    Photodermatol Photoimmunol Photomed; 2018 May; 34(3):175-183. PubMed ID: 29080365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.